Intra-Cellular Therapies Statistics
Total Valuation
FRA:3PC has a market cap or net worth of EUR 2.02 billion. The enterprise value is 2.00 billion.
Market Cap | 2.02B |
Enterprise Value | 2.00B |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | May 19, 2025 |
Share Statistics
Current Share Class | 155.52M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.00% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 58.10M |
Valuation Ratios
The trailing PE ratio is 11.33 and the forward PE ratio is 9.75.
PE Ratio | 11.33 |
Forward PE | 9.75 |
PS Ratio | 1.21 |
PB Ratio | 1.12 |
P/TBV Ratio | 1.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 11.23 |
EV / Sales | 1.20 |
EV / EBITDA | 5.36 |
EV / EBIT | 8.95 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.09.
Current Ratio | 2.01 |
Quick Ratio | 1.38 |
Debt / Equity | 0.09 |
Debt / EBITDA | 0.45 |
Debt / FCF | n/a |
Interest Coverage | 19.79 |
Financial Efficiency
Return on equity (ROE) is 10.30% and return on invested capital (ROIC) is 7.05%.
Return on Equity (ROE) | 10.30% |
Return on Assets (ROA) | 5.43% |
Return on Invested Capital (ROIC) | 7.05% |
Return on Capital Employed (ROCE) | 10.35% |
Revenue Per Employee | 539,137 |
Profits Per Employee | 57,422 |
Employee Count | 3,082 |
Asset Turnover | 0.65 |
Inventory Turnover | 4.56 |
Taxes
In the past 12 months, FRA:3PC has paid 57.85 million in taxes.
Income Tax | 57.85M |
Effective Tax Rate | 24.06% |
Stock Price Statistics
The stock price has increased by +26.30% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +26.30% |
50-Day Moving Average | 14.30 |
200-Day Moving Average | 12.58 |
Relative Strength Index (RSI) | 32.59 |
Average Volume (20 Days) | 187 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:3PC had revenue of EUR 1.67 billion and earned 178.18 million in profits. Earnings per share was 1.15.
Revenue | 1.67B |
Gross Profit | 596.52M |
Operating Income | 222.50M |
Pretax Income | 240.46M |
Net Income | 178.18M |
EBITDA | 333.08M |
EBIT | 222.50M |
Earnings Per Share (EPS) | 1.15 |
Balance Sheet
The company has 309.48 million in cash and 167.84 million in debt, giving a net cash position of 141.64 million.
Cash & Cash Equivalents | 309.48M |
Total Debt | 167.84M |
Net Cash | 141.64M |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.81B |
Book Value Per Share | 10.82 |
Working Capital | 420.79M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 35.66%, with operating and profit margins of 13.30% and 10.65%.
Gross Margin | 35.66% |
Operating Margin | 13.30% |
Pretax Margin | 14.37% |
Profit Margin | 10.65% |
EBITDA Margin | 19.91% |
EBIT Margin | 13.30% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.28, which amounts to a dividend yield of 2.13%.
Dividend Per Share | 0.28 |
Dividend Yield | 2.13% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 3 |
Payout Ratio | n/a |
Buyback Yield | -0.00% |
Shareholder Yield | 2.13% |
Earnings Yield | 8.83% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
FRA:3PC has an Altman Z-Score of 2.61 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.61 |
Piotroski F-Score | 3 |